Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Jun 15, 2021; 13(6): 589-599
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.589
Table 1 Preoperative demographic data and clinical radiological characteristics
Demographic data (n = 14)
n (%)
Gender
Female/male14 (100)/0 (0)
Mean age (yr); (range)31.6 (20-55)
35 yr11 (78.6)
Symptoms
Asymptomatic12 (85.7)
Abdominal pain and vomiting1 (7.1)
Jaundice/weight loss1 (7.1)
Radiological characteristics
Largest injury (cm)18
Minor injury (cm)1.5
Average lesion size (cm); (range)6.7 (1.5-18)
Tumor location
Head6 (42.8)
Body/tail8 (57.1)
Metastasis
Yes0
No14 (100)
Lymph node enlargement0
Vascular invasion2 (14.3)
Table 2 Intraoperative surgical data
Intraoperative characteristics (n = 14)
n (%)
Access way
Laproscopic5 (38.4)
Open Laparotomy9 (64.2)
Type of surgery
Duodenopancreatectomy6 (42.8)
Distal pancreatectomy8 (57.1)
Vascular resection
Yes2 (14.2)
No12 (85.7)
Resection of other organs
Yes8 (57.1)
Spleen(7)
Transverse colon(1)
Stomach(1)
No6 (42.8)
Blood transfusion
Yes2 (14.2)
No12 (85.7)
Table 3 Postoperative characteristics, adverse events (classification and treatment), readmission, and deaths
Postoperative characteristics (n = 14)
n (%)
Clavien-Dindo
Abdominal drain14 (100)-
Surgical site (adverse events)4 (28.5)-
Surgical wound infection (PD)1 (7.1)II (Antibiotic)
Transient liver failure/ascites (PD)1 (7.1)I
Grade C pancreatic fistula (CCP); Grade B pancreatic fistula (CCP) 1 (7.1); 1 (7.1)III (EL); II (abdominal drain)
Surgical site (adverse events outside)1 (7.1)
Urinary infection (PD)1 (7.1)II (Antibiotic)
Readmission1 (7.1)Grade C fistula (EL)
Death up to 90 d0
Table 4 Pathological characteristics (n = 14)
Pathological characteristics
n (%)
Free surgical margins14 (100)
Average of resected lymph nodes6.5
Lymph node metastasis0
Perineural invasion0
Angiolymphatic invasion0
Microscopic extension of the tumor1
Peripancreatic adipose tissue1
Invasion of the capsule0
Table 5 Follow-up of patients with solid pseudopapillary neoplasm of the pancreas
Year of surgery
n
Follow-up (yr)Disease free
Conduct
1998113YesMD
199811YesDeath1
201245YesMD
201315YesMD
201425YesMD
201525YesMD
201713YesSG
201822YesSG
Table 6 Incidental and symptoms in patients with solid pseudopapillary neoplasms (literature data)
Ref.
Year
n
Study
Incidental (%)
Ap (%)
Other findings (%)
Papavramidis et al[15]2006718R15.546.5Mass 34.8
Lubezky et al[16]201732R2848Unspecific 24
Song et al[17]201753R39.637.7Mass 30.2
Wright et al[6]201978R30.742.3Nauseas 14.1
Lin et al[18]201960R6531.7Strain 2.2
Torres et al[19]201916R-87.5Mass 12.5
Liu et al[20]2019243R63.419Unspecific
Farhat et al[21]202010R2040Mass 40